RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 69.65
+7.10 (11.35%)
Nov 4, 2026, 2:45 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 53.76 billion as of November 3, 2026. It is the 2,904th most valuable company in the world and the 154th biggest in Hong Kong. Its market cap has decreased by 4.98% in one year.
Market Cap
53.76B
Enterprise Value
47.65B
Revenue
9.70B
Global Rank
Country Rank
#154 Hong Kong
PE Ratio
5.13
ChartMarket Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 53.76B, an increase of 61.01%. That is a compound annual growth rate of 8.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 53.76B | 18.94% |
| Dec 31, 2025 | 45.20B | 222.75% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical | 101.68B |
| Sino Biopharmaceutical | 86.65B |
| Genscript Biotech | 81.55B |
| Akeso | 74.26B |
| Biocytogen Pharmaceuticals (Beijing) | 35.11B |
| 3SBio | 34.09B |
| Shanghai Junshi Biosciences | 30.36B |
| Shanghai Henlius Biotech | 26.04B |